Close Menu

The Scan

The UK Health Secretary touts newborn sequencing benefits.

A Genetic Appeal?

New Mexico's Supreme Court considers an appeal in the case of a convicted murderer with a MAOA gene mutation.

Prosecutors in Atlanta look into alleged fraud cases based on unnecessary genetic testing.

An ancient Egyptian emmer wheat genome and genetic approaches for boosting crop yield.

A precedent-setting warrant allowed a Florida detective to access data from all GEDmatch users.

Some T Cell Tweaks

Doctors are gearing up to report on early results for three cancer patients who received immunotherapy based on CRISPR-edited T cells.

A University of Brighton team is pursuing a genetic test for blood doping methods to increase red blood cell levels.

Strategies for sequencing formalin-fixed, paraffin-embedded 5' RNA ends; tumor phylogeny from single-cell and bulk data; a chromosome-level look at the Atlantic herring genome.

The drug works to improve cognitive function in Alzheimer's patients by altering their gut microbiomes, ScienceInsider reports.

Don't Be So Gloomy

A British scientist says Brexit could actually be good for science in the UK.

The New York Times reports there are nearly 200 investigations into potential theft of intellectual property at biomedical research institutions.

In PNAS this week: gut microbiome-diet relationships in large, East African herbivore species, breast cancer features that boost susceptibility to neoadjuvant chemotherapy, and more.

CNN reports that President Donald Trump is to nominate Stephen Hahn as the next Food and Drug Administration commissioner.

The Associated Press reports that an analysis suggests bison are losing their genetic diversity.

Maybe Someday a Test

Researchers in the UK uncovered auto-antibodies that might be able to be used to uncover breast cancer, the Guardian reports.

In PLOS this week: computational approach, analysis of chronic granulomas, and more.

Not a Dime Again

A former Duke University biologist who was found to have fabricated data in 39 papers has been banned from receiving federal funding.

About Those Chips

The dispute regarding the Wellcome Sanger Institute's use of DNA samples from African individuals could weaken trust between researchers and African populations, Science writes.

Quick Confirmation

The Scientist writes that the announcement of Islamic State's Abu Bakr al-Baghdadi's death suggested that his identity might have been confirmed with rapid DNA testing.

In Science this week: DNA exchange influences diversity among Heliconius butterflies, and more.

The American Association for the Advancement of Science names Sudip Parikh as its next CEO.

Some Shrinking

New Scientist writes that experimental cancer drug from Amgen appears effective at targeting cancers with KRAS mutations.

For a Number Boost

PBS NewsHour reports on initiatives that aim to bolster the representation of minority groups in research.

In Nature this week: residual protein expression uncovered for a third of CRISPR targets, and more.

Pause Button Hit

Novartis has paused a trial of its Zolgensma gene therapy that treats spinal muscular atrophy, the Wall Street Journal reports.

Pages

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.